Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a dismal prognosis, especially when diagnosed at advanced stages. Annexin A2 (ANXA2), is found to promote cancer progression and therapeutic resistance. However, the underlining mechanisms of ANXA2 in immune escape of HCC re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Qiu, Li-Wei, Liu, Yi-Fei, Cao, Xiao-Qing, Wang, Yan, Cui, Xiao-Hong, Ye, Xian, Huang, Shuo-Wen, Xie, Hong-Jun, Zhang, Hai-Jian
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2020
Matèries:
Opinion Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7235202/
https://ncbi.nlm.nih.gov/pubmed/32476780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i18.2126
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars